Alves L E, Rose E P, Cahill T B
Crit Care Med. 1985 Sep;13(9):750-2. doi: 10.1097/00003246-198509000-00012.
Oral amiodarone's slow absorption handicaps rapid treatment of life-threatening arrhythmias. We used iv amiodarone to treat ten patients with hemodynamically significant atrial arrhythmias and life-threatening ventricular arrhythmias refractory to all conventional medical treatment. Arrhythmias were controlled in nine patients, five of whom became long-term survivors on oral amiodarone. Two patients died of cardiovascular collapse within 24 h of initiation of iv amiodarone. One other patient died postoperatively of cardiovascular collapse while on oral amiodarone, 2 wk after iv amiodarone. Another patient died of an unrelated cause 13 months after initiation of amiodarone. These results suggest that iv amiodarone is effective in controlling refractory atrial and ventricular arrhythmias and may shorten the latency period.
口服胺碘酮吸收缓慢,不利于对危及生命的心律失常进行快速治疗。我们使用静脉注射胺碘酮治疗了10例血流动力学显著的房性心律失常患者以及对所有传统药物治疗均无效的危及生命的室性心律失常患者。9例患者的心律失常得到控制,其中5例在口服胺碘酮后成为长期存活者。2例患者在开始静脉注射胺碘酮后24小时内死于心血管衰竭。另1例患者在静脉注射胺碘酮2周后口服胺碘酮期间术后死于心血管衰竭。另1例患者在开始使用胺碘酮13个月后死于无关原因。这些结果表明,静脉注射胺碘酮在控制难治性房性和室性心律失常方面有效,并且可能缩短潜伏期。